Enes Taylan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Enes Taylan has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
Kutluk Oktay
8 shared publicationsAli Akdemir
Department of Obstetrics and Gynecology, Ege University School of Medicine , Izmir , Turkey
6 shared publicationsAhmet Mete Ergenoglu
Department of Obstetrics and Gynecology, Ege University School of Medicine, Izmir, Turkey
4 shared publications- Ahmet Ozgur Yeniel
Department of Obstetrics and Gynecology, Ege University Schhol of Medicine, Izmir, Türkiye
4 shared publications - Ali Akdemir
Department of Obstetrics and Gynecology, Faculty of Medicine, Ege University, Izmir 35100, Turkey
4 shared publications - Cagdas Sahin
Ege University, Faculty School of Medicine, Department of Obstetrics and Gynecology
4 shared publications
Latest Publications
- Open Access
- 15 February 2024
- Published by Springer Nature in npj Precision Oncology
- Vol. 8 (1) , 1-13
INHBA(+) cancer-associated fibroblasts generate an immunosuppressive tumor microenvironment in ovarian cancer
Effective targeting of cancer-associated fibroblasts (CAFs) is hindered by the lack of specific biomarkers and a poor understanding of the mechanisms by which different populations of CAFs contribute to cancer progression. While the role of TGFβ in CAFs is well-studied, less attention has been focused on a structurally and functionally similar protein, Activin A (encoded by INHBA). Here, we identified INHBA(+) CAFs as key players in tumor promotion and immunosuppression. Spatiotemporal analyses of patient-matched primary, metastatic, and recurrent ovarian carcinomas revealed that aggressive metastatic tumors enriched in INHBA(+) CAFs were also enriched in regulatory T cells (Tregs). In ovarian cancer mouse models, intraperitoneal injection of the Activin A neutralizing antibody attenuated tumor progression and infiltration with pro-tumorigenic subsets of myofibroblasts and macrophages. Downregulation of INHBA in human ovarian CAFs inhibited pro-tumorigenic CAF functions. Co-culture of human ovarian CAFs and T cells revealed the dependence of Treg differentiation on direct contact with INHBA(+) CAFs. Mechanistically, INHBA/recombinant Activin A in CAFs induced the autocrine expression of PD-L1 through SMAD2-dependent signaling, which promoted Treg differentiation. Collectively, our study identified an INHBA(+) subset of immunomodulatory pro-tumoral CAFs as a potential therapeutic target in advanced ovarian cancers which typically show a poor response to immunotherapy.
- 15 February 2024
- Published by Springer Nature in npj Precision Oncology
- Vol. 8 (1) , 1-13
Open AccessINHBA(+) cancer-associated fibroblasts generate an immunosuppressive tumor microenvironment in ovarian cancer
Effective targeting of cancer-associated fibroblasts (CAFs) is hindered by the lack of specific biomarkers and a poor understanding of the mechanisms by which different populations of CAFs contribute to cancer progression. While the role of TGFβ in CAFs is well-studied, less attention has been focused on a structurally and functionally similar protein, Activin A (encoded by INHBA). Here, we identified INHBA(+) CAFs as key players in tumor promotion and immunosuppression. Spatiotemporal analyses of patient-matched primary, metastatic, and recurrent ovarian carcinomas revealed that aggressive metastatic tumors enriched in INHBA(+) CAFs were also enriched in regulatory T cells (Tregs). In ovarian cancer mouse models, intraperitoneal injection of the Activin A neutralizing antibody attenuated tumor progression and infiltration with pro-tumorigenic subsets of myofibroblasts and macrophages. Downregulation of INHBA in human ovarian CAFs inhibited pro-tumorigenic CAF functions. Co-culture of human ovarian CAFs and T cells revealed the dependence of Treg differentiation on direct contact with INHBA(+) CAFs. Mechanistically, INHBA/recombinant Activin A in CAFs induced the autocrine expression of PD-L1 through SMAD2-dependent signaling, which promoted Treg differentiation. Collectively, our study identified an INHBA(+) subset of immunomodulatory pro-tumoral CAFs as a potential therapeutic target in advanced ovarian cancers which typically show a poor response to immunotherapy.
- Open Access
- 11 March 2023
- Published by MDPI AG in Biomolecules
- Vol. 13 (3) , 515
Stability Determination of Intact Humanin-G with Characterizations of Oxidation and Dimerization Patterns
Humanin is the first identified mitochondrial-derived peptide. Humanin-G (HNG) is a variant of Humanin that has significantly higher cytoprotective properties. Here, we describe the stability features of HNG in different conditions and characterize HNG degradation, oxidation, and dimerization patterns over short-term and long-term periods. HNG solutions were prepared in high-performance liquid chromatography (HPLC) water or MO formulation and stored at either 4 °C or 37 °C. Stored HNG samples were analyzed using HPLC and high-resolution mass spectrometry (HRMS). Using HPLC, full-length HNG peptides in HPLC water decreased significantly with time and higher temperature, while HNG in MO formulation remained stable up to 95% at 4 °C on day 28. HNG peptides in HPLC water, phosphate-buffered saline (PBS) and MO formulation were incubated at 37 °C and analyzed at day 1, day 7 and day 14 using HRMS. Concentrations of full-length HNG peptide in HPLC water and PBS declined over time with a corresponding appearance of new peaks that increased over time. These new peaks were identified to be singly oxidized HNG, doubly oxidized HNG, homodimerized HNG, singly oxidized homodimerized HNG, and doubly oxidized homodimerized HNG. Our results may help researchers improve the experimental design to further understand the critical role of HNG in human diseases.
- 11 March 2023
- Published by MDPI AG in Biomolecules
- Vol. 13 (3) , 515
Open AccessStability Determination of Intact Humanin-G with Characterizations of Oxidation and Dimerization Patterns
Humanin is the first identified mitochondrial-derived peptide. Humanin-G (HNG) is a variant of Humanin that has significantly higher cytoprotective properties. Here, we describe the stability features of HNG in different conditions and characterize HNG degradation, oxidation, and dimerization patterns over short-term and long-term periods. HNG solutions were prepared in high-performance liquid chromatography (HPLC) water or MO formulation and stored at either 4 °C or 37 °C. Stored HNG samples were analyzed using HPLC and high-resolution mass spectrometry (HRMS). Using HPLC, full-length HNG peptides in HPLC water decreased significantly with time and higher temperature, while HNG in MO formulation remained stable up to 95% at 4 °C on day 28. HNG peptides in HPLC water, phosphate-buffered saline (PBS) and MO formulation were incubated at 37 °C and analyzed at day 1, day 7 and day 14 using HRMS. Concentrations of full-length HNG peptide in HPLC water and PBS declined over time with a corresponding appearance of new peaks that increased over time. These new peaks were identified to be singly oxidized HNG, doubly oxidized HNG, homodimerized HNG, singly oxidized homodimerized HNG, and doubly oxidized homodimerized HNG. Our results may help researchers improve the experimental design to further understand the critical role of HNG in human diseases.
- 1 March 2022
- Published by Oxford University Press (OUP)
- p. 1376-1381
Female Infertility
Fertility preservation is an emerging field which aims to develop and utilize effective treatment options for women under risk of ovarian insufficiency (OI) due to a wide range of conditions from chromosomal disorders to antineoplastic treatments and surgical interventions that can cause loss of ovarian follicle reserve. Irreversible loss of fertility and ovarian endocrine function can have a negative impact on women’s physiological and psychosocial health. Therefore, preservation of fertility in reproductive age women is a critical component of modern healthcare and improved quality of life. In this chapter, we will review the current status and future perspectives of the field of fertility preservation as an emerging branch of assisted reproductive technologies.
- 1 March 2022
- Published by Oxford University Press (OUP)
- p. 1376-1381
Female Infertility
Fertility preservation is an emerging field which aims to develop and utilize effective treatment options for women under risk of ovarian insufficiency (OI) due to a wide range of conditions from chromosomal disorders to antineoplastic treatments and surgical interventions that can cause loss of ovarian follicle reserve. Irreversible loss of fertility and ovarian endocrine function can have a negative impact on women’s physiological and psychosocial health. Therefore, preservation of fertility in reproductive age women is a critical component of modern healthcare and improved quality of life. In this chapter, we will review the current status and future perspectives of the field of fertility preservation as an emerging branch of assisted reproductive technologies.
- Open Access
- 16 August 2021
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 38 (10) , 2723-2733
Comparison of open and a novel closed vitrification system with slow freezing for human ovarian tissue cryopreservation
Purpose To investigate the differences concerning post-thawing/warming follicle survival, DNA damage and apoptosis in human ovarian tissues cryopreserved by slow freezing, open, or closed vitrification methods. Methods A total of 50 pieces of 5 × 5 × 1 mm ovarian cortical pieces were harvested (5 donor ovaries; mean age 31 ± 6.62 years). From each donor, one cortical piece was used as baseline; the remaining were randomly assigned to slow freezing (SF), vitrification using open device (VF-open), or closed device (VF-closed) groups. After 8–10 weeks of cryostorage, tissues were evaluated 4 h after thawing/warming. Histological analysis was evaluated for follicle survival (primordial and primary follicle densities) by H&E staining. The percentages of primordial and primary follicles with DNA double-strand breaks (γH2AX) and apoptotic cell death pathway activation (AC3) were immunohistochemically assessed. Data were analysed using one-way ANOVA and LSD post hoc comparison. Results Compared to the baseline, primordial follicle (pdf) densities significantly declined in all cryopreserved groups (SF, VF-open, and VF-closed, P < 0.05). However, the total and non-apoptotic pdf densities were similar among SF, VF-open, and VF-closed. SF and VF with either open or closed devices did not increase the percentages of primordial or primary follicles with DNA double-strand breaks (DSBs) or apoptosis compared to the baseline or among the freezing methods in the present study. Conclusion Based on the intact primordial follicle survival, DNA damage, and apoptosis rates after thawing/warming, SF vs VF with either open or newly developed closed devices appear to be comparable.
- 16 August 2021
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 38 (10) , 2723-2733
Open AccessComparison of open and a novel closed vitrification system with slow freezing for human ovarian tissue cryopreservation
Purpose To investigate the differences concerning post-thawing/warming follicle survival, DNA damage and apoptosis in human ovarian tissues cryopreserved by slow freezing, open, or closed vitrification methods. Methods A total of 50 pieces of 5 × 5 × 1 mm ovarian cortical pieces were harvested (5 donor ovaries; mean age 31 ± 6.62 years). From each donor, one cortical piece was used as baseline; the remaining were randomly assigned to slow freezing (SF), vitrification using open device (VF-open), or closed device (VF-closed) groups. After 8–10 weeks of cryostorage, tissues were evaluated 4 h after thawing/warming. Histological analysis was evaluated for follicle survival (primordial and primary follicle densities) by H&E staining. The percentages of primordial and primary follicles with DNA double-strand breaks (γH2AX) and apoptotic cell death pathway activation (AC3) were immunohistochemically assessed. Data were analysed using one-way ANOVA and LSD post hoc comparison. Results Compared to the baseline, primordial follicle (pdf) densities significantly declined in all cryopreserved groups (SF, VF-open, and VF-closed, P < 0.05). However, the total and non-apoptotic pdf densities were similar among SF, VF-open, and VF-closed. SF and VF with either open or closed devices did not increase the percentages of primordial or primary follicles with DNA double-strand breaks (DSBs) or apoptosis compared to the baseline or among the freezing methods in the present study. Conclusion Based on the intact primordial follicle survival, DNA damage, and apoptosis rates after thawing/warming, SF vs VF with either open or newly developed closed devices appear to be comparable.
- Open Access
In Vivo Mechanisms of Chemotherapy-Induced Acute Follicle Loss in the Human Ovary: An Individual-Oocyte Transcriptomic Analysis from Human Ovarian Xenografts
Gonadotoxic chemotherapeutics, such as cyclophosphamide, cause early menopause and infertility in women. Earlier histological studies showed ovarian reserve depletion via severe DNA damage and apoptosis, but others suggested activation of PI3K/PTEN/Akt pathway and follicle ‘burn-out’ as a cause. Using a human ovarian xenograft model, we performed single-cell RNA-sequencing on laser-captured individual primordial follicle oocytes 12h after a single cyclophosphamide injection to determine the mechanisms of acute follicle loss after gonadotoxic chemotherapy. RNA-sequencing showed 190 differentially expressed genes between the cyclophosphamide- and vehicle-exposed oocytes. Ingenuity Pathway Analysis predicted a significant decrease in the expression of anti-apoptotic pro-Akt PECAM1 (p=2.13E-09), IKBKE (p=0.0001), and ANGPT1 (p=0.003), and reduced activation of PI3K/PTEN/Akt after cyclophosphamide. The qRT-PCR and immunostaining confirmed that in primordial follicle oocytes, cyclophosphamide did not change the expressions of Akt (p=0.9), rpS6 (p=0.3), Foxo3a (p=0.12) and anti-apoptotic Bcl2 (p=0.17), nor affect their phosphorylation status. There was significantly increased DNA damage by γH2AX (p=0.0002) and apoptosis by active-caspase-3 (p=0.0001) staining in the primordial follicles and no change in the growing follicles 12h after chemotherapy. These data suggest that the mechanism of acute follicle loss by cyclophosphamide is via apoptosis, rather than growth activation of primordial follicle oocytes in the human ovary. One Sentence Summary: Single-cell transcriptomic interrogation of primordial follicles in human ovarian xenografts reveals that chemotherapy causes acute ovarian reserve depletion by inducing a pro-apoptotic state rather than activating pathways that result in follicle growth initiation.
Open AccessIn Vivo Mechanisms of Chemotherapy-Induced Acute Follicle Loss in the Human Ovary: An Individual-Oocyte Transcriptomic Analysis from Human Ovarian Xenografts
Gonadotoxic chemotherapeutics, such as cyclophosphamide, cause early menopause and infertility in women. Earlier histological studies showed ovarian reserve depletion via severe DNA damage and apoptosis, but others suggested activation of PI3K/PTEN/Akt pathway and follicle ‘burn-out’ as a cause. Using a human ovarian xenograft model, we performed single-cell RNA-sequencing on laser-captured individual primordial follicle oocytes 12h after a single cyclophosphamide injection to determine the mechanisms of acute follicle loss after gonadotoxic chemotherapy. RNA-sequencing showed 190 differentially expressed genes between the cyclophosphamide- and vehicle-exposed oocytes. Ingenuity Pathway Analysis predicted a significant decrease in the expression of anti-apoptotic pro-Akt PECAM1 (p=2.13E-09), IKBKE (p=0.0001), and ANGPT1 (p=0.003), and reduced activation of PI3K/PTEN/Akt after cyclophosphamide. The qRT-PCR and immunostaining confirmed that in primordial follicle oocytes, cyclophosphamide did not change the expressions of Akt (p=0.9), rpS6 (p=0.3), Foxo3a (p=0.12) and anti-apoptotic Bcl2 (p=0.17), nor affect their phosphorylation status. There was significantly increased DNA damage by γH2AX (p=0.0002) and apoptosis by active-caspase-3 (p=0.0001) staining in the primordial follicles and no change in the growing follicles 12h after chemotherapy. These data suggest that the mechanism of acute follicle loss by cyclophosphamide is via apoptosis, rather than growth activation of primordial follicle oocytes in the human ovary. One Sentence Summary: Single-cell transcriptomic interrogation of primordial follicles in human ovarian xenografts reveals that chemotherapy causes acute ovarian reserve depletion by inducing a pro-apoptotic state rather than activating pathways that result in follicle growth initiation.
- Open Access
LONGITUDINAL OVARIAN RESERVE CHANGES IN WOMEN WITH BREAST CANCER RECEIVING ADJUVANT CHEMOTHERAPY OR TAMOXIFEN-ALONE
Background: To determine the longitudinal impact of adjuvant chemotherapy and tamoxifen-only treatments on ovarian reserve by serum anti-Mullerian hormone (AMH) levels in women with breast cancer. Methods: One-hundred-and-forty-two women with a primary diagnosis of breast cancer were prospectively followed with serum AMH assessments before the initiation, and 12, 18 and 24 months after the completion of adjuvant chemotherapy or the start of tamoxifen-only treatment. The chemotherapy regimens were classified into Anthracycline-Cyclophosphamide-based (AC-based) and Cyclophosphamide-Methotrexate+5-Fluorouracil (CMF). Longitudinal data were analyzed by mixed effects model for treatment effects over time, adjusting for baseline age and BMI. Results: Both chemotherapy regimens resulted in significant decline in ovarian reserve compared to the tamoxifen-only treatment (p<0.0001 either regimen vs. tamoxifen for overall trend). AMH levels sharply declined at 12 months but did not show a significant recovery from 12 to 18 and 18 to 24 months after the completion of AC-based or CMF regimens. The degree of decline did not differ between the two chemotherapy groups (p=0.53). In contrast, tamoxifen-only treatment did not significantly alter the age-adjusted serum AMH levels over the 24-month follow up. Likewise, the use of adjuvant tamoxifen following AC-based regimens did not affect AMH recovery. Conclusions: Both AC-based and CMF regimens significantly compromise ovarian reserve, which does not recover during the 12-24-month post-chemotherapy follow up. In contrast, tamoxifen treatment does not seem to alter ovarian reserve. This novel information should be valuable for fertility preservation counselling and in assessing future reproductive potential of breast cancer survivors.
Open AccessLONGITUDINAL OVARIAN RESERVE CHANGES IN WOMEN WITH BREAST CANCER RECEIVING ADJUVANT CHEMOTHERAPY OR TAMOXIFEN-ALONE
Background: To determine the longitudinal impact of adjuvant chemotherapy and tamoxifen-only treatments on ovarian reserve by serum anti-Mullerian hormone (AMH) levels in women with breast cancer. Methods: One-hundred-and-forty-two women with a primary diagnosis of breast cancer were prospectively followed with serum AMH assessments before the initiation, and 12, 18 and 24 months after the completion of adjuvant chemotherapy or the start of tamoxifen-only treatment. The chemotherapy regimens were classified into Anthracycline-Cyclophosphamide-based (AC-based) and Cyclophosphamide-Methotrexate+5-Fluorouracil (CMF). Longitudinal data were analyzed by mixed effects model for treatment effects over time, adjusting for baseline age and BMI. Results: Both chemotherapy regimens resulted in significant decline in ovarian reserve compared to the tamoxifen-only treatment (p<0.0001 either regimen vs. tamoxifen for overall trend). AMH levels sharply declined at 12 months but did not show a significant recovery from 12 to 18 and 18 to 24 months after the completion of AC-based or CMF regimens. The degree of decline did not differ between the two chemotherapy groups (p=0.53). In contrast, tamoxifen-only treatment did not significantly alter the age-adjusted serum AMH levels over the 24-month follow up. Likewise, the use of adjuvant tamoxifen following AC-based regimens did not affect AMH recovery. Conclusions: Both AC-based and CMF regimens significantly compromise ovarian reserve, which does not recover during the 12-24-month post-chemotherapy follow up. In contrast, tamoxifen treatment does not seem to alter ovarian reserve. This novel information should be valuable for fertility preservation counselling and in assessing future reproductive potential of breast cancer survivors.
- 9 March 2020
- Published by H1 Connect
Faculty Opinions recommendation of Single-Cell Transcriptomic Atlas of Primate Ovarian Aging.
The ovary is the primary source of female sex hormones and the only source of oocytes. The vast majority of oocytes remain quiescent in the human ovary for decades, before initiating growth. This renders human oocytes to the accumulation of external influences and chronic DNA damage, which culminate into an age-accelerated functional decline which clinically present as infertility and menopause. Hence, identifying the underlying molecular mechanisms of ovarian aging may lead to novel therapeutic approaches to treating infertility and delaying menopause. In a recent study, using single-cell RNA sequencing technology, Wang et al. systematically characterized genetic signatures of various cell types in the ovaries from four young and four old cynomolgus monkeys. They identified six ovarian somatic cell types and four subtypes of oocyte with unique transcriptional signatures such as FIGLA for oocytes, NR5A2 for granulosa cells (GC), and TCF21 for stromal cells. Also, they discovered novel genetic markers such as LMOD3, RBM46, and NETO1 at different developmental stages of folliculogenesis. Remarkably, the researchers showed significantly decreased expression of anti-oxidant genes, including GPX1 and GSR in early stage oocytes of aged monkeys, suggesting oxidative damage as an essential factor in ovarian aging. Similarly, they observed increased DNA oxidation and damage along with apoptosis in GCs of aged monkeys. Consistent with their results in cynomolgus monkeys, the authors reported increased reactive oxygen species and apoptosis with decreased expression of anti-oxidant genes in human GCs obtained from healthy donors. In fact, these findings are consistent with our earlier report showing increased DNA damage and reduced DNA repair mechanisms in human and mouse oocytes {1,2}. This study is the first comprehensive single-cell transcriptomic analysis of ovaries from young and aged non-human primates introducing an invaluable resource for cell-type-specific genetic signatures in the primate ovary. Moreover, it proposes increased oxidative stress as a potential therapeutic target for ovarian aging. Future studies are needed to determine transcriptomic signatures of aging in human primordial follicles.
- 9 March 2020
- Published by H1 Connect
Faculty Opinions recommendation of Single-Cell Transcriptomic Atlas of Primate Ovarian Aging.
The ovary is the primary source of female sex hormones and the only source of oocytes. The vast majority of oocytes remain quiescent in the human ovary for decades, before initiating growth. This renders human oocytes to the accumulation of external influences and chronic DNA damage, which culminate into an age-accelerated functional decline which clinically present as infertility and menopause. Hence, identifying the underlying molecular mechanisms of ovarian aging may lead to novel therapeutic approaches to treating infertility and delaying menopause. In a recent study, using single-cell RNA sequencing technology, Wang et al. systematically characterized genetic signatures of various cell types in the ovaries from four young and four old cynomolgus monkeys. They identified six ovarian somatic cell types and four subtypes of oocyte with unique transcriptional signatures such as FIGLA for oocytes, NR5A2 for granulosa cells (GC), and TCF21 for stromal cells. Also, they discovered novel genetic markers such as LMOD3, RBM46, and NETO1 at different developmental stages of folliculogenesis. Remarkably, the researchers showed significantly decreased expression of anti-oxidant genes, including GPX1 and GSR in early stage oocytes of aged monkeys, suggesting oxidative damage as an essential factor in ovarian aging. Similarly, they observed increased DNA oxidation and damage along with apoptosis in GCs of aged monkeys. Consistent with their results in cynomolgus monkeys, the authors reported increased reactive oxygen species and apoptosis with decreased expression of anti-oxidant genes in human GCs obtained from healthy donors. In fact, these findings are consistent with our earlier report showing increased DNA damage and reduced DNA repair mechanisms in human and mouse oocytes {1,2}. This study is the first comprehensive single-cell transcriptomic analysis of ovaries from young and aged non-human primates introducing an invaluable resource for cell-type-specific genetic signatures in the primate ovary. Moreover, it proposes increased oxidative stress as a potential therapeutic target for ovarian aging. Future studies are needed to determine transcriptomic signatures of aging in human primordial follicles.
- 17 July 2019
- Published by H1 Connect
Faculty Opinions recommendation of Germline de novo mutation clusters arise during oocyte aging in genomic regions with high double-strand-break incidence.
Uncovering the underlying mechanisms of the aging process in the human ovary, particularly in oocytes, is of great importance due to its potential clinical implications for the treatment of infertility {1}. We have previously shown that in BRCA mutation carriers, accumulated DNA double-strand breaks (DSBs) in oocytes due to impaired DNA repair are a central feature of oocyte aging and infertility {2}. Supporting our findings, in the study by Goldmann et al., researchers investigated the germline de novo mutation clusters (cDNMs) in the whole-genome sequencing data from 1291 parent-offspring trios and found that cDNMs are significantly associated with maternal age and DNA DSBs. Based on their results, researchers suggested that the primary mechanism underlying the formation of maternal mutation clusters is the accumulation of DSB induced mutations throughout oocyte aging. This study further expands our knowledge in understanding the relationship between DNA damage and oocyte aging processes and may provide an insight into the treatment of female infertility.
- 17 July 2019
- Published by H1 Connect
Faculty Opinions recommendation of Germline de novo mutation clusters arise during oocyte aging in genomic regions with high double-strand-break incidence.
Uncovering the underlying mechanisms of the aging process in the human ovary, particularly in oocytes, is of great importance due to its potential clinical implications for the treatment of infertility {1}. We have previously shown that in BRCA mutation carriers, accumulated DNA double-strand breaks (DSBs) in oocytes due to impaired DNA repair are a central feature of oocyte aging and infertility {2}. Supporting our findings, in the study by Goldmann et al., researchers investigated the germline de novo mutation clusters (cDNMs) in the whole-genome sequencing data from 1291 parent-offspring trios and found that cDNMs are significantly associated with maternal age and DNA DSBs. Based on their results, researchers suggested that the primary mechanism underlying the formation of maternal mutation clusters is the accumulation of DSB induced mutations throughout oocyte aging. This study further expands our knowledge in understanding the relationship between DNA damage and oocyte aging processes and may provide an insight into the treatment of female infertility.
- 1 March 2019
- Published by Elsevier in Fertility and Sterility
- Vol. 111 (3) , 604-606
Robot-assisted orthotopic and heterotopic ovarian tissue transplantation techniques: surgical advances since our first success in 2000
- 1 March 2019
- Published by Elsevier in Fertility and Sterility
- Vol. 111 (3) , 604-606
Robot-assisted orthotopic and heterotopic ovarian tissue transplantation techniques: surgical advances since our first success in 2000
- Open Access
- 1 February 2019
- Published by Trakya University Journal of Natural Sciences in Trakya University Journal of Natural Sciences
- Vol. 20, 63-66
CURRENT STATUS OF GERMLINE STEM CELLS IN ADULT MAMMALIAN OVARY
The evolutionary and biological mechanisms underlying female reproductive aging have long been a matter of interest. Reproductive biologists have tackled with the relatively limited fertile period in female lifespan compared to male fertility that continues until the late ages. For more than five decades, it has been believed that females are born with a fixed number of germ cells that constitute ovarian follicle reserve and depletion of this reserve causes menopause. However, researchers recently reported findings that support the presence of oogenesis in postnatal mammalian ovaries, which caused a paradigm shift in our current knowledge of reproductive biology. In this minireview, we provide a brief history of one of the central dogmas in reproductive biology and subsequently present recent studies on the existence of germline stem cells in the mammalian ovary.
- 1 February 2019
- Published by Trakya University Journal of Natural Sciences in Trakya University Journal of Natural Sciences
- Vol. 20, 63-66
Open AccessCURRENT STATUS OF GERMLINE STEM CELLS IN ADULT MAMMALIAN OVARY
The evolutionary and biological mechanisms underlying female reproductive aging have long been a matter of interest. Reproductive biologists have tackled with the relatively limited fertile period in female lifespan compared to male fertility that continues until the late ages. For more than five decades, it has been believed that females are born with a fixed number of germ cells that constitute ovarian follicle reserve and depletion of this reserve causes menopause. However, researchers recently reported findings that support the presence of oogenesis in postnatal mammalian ovaries, which caused a paradigm shift in our current knowledge of reproductive biology. In this minireview, we provide a brief history of one of the central dogmas in reproductive biology and subsequently present recent studies on the existence of germline stem cells in the mammalian ovary.